Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|February 2, 2011
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosaGlenn A Pankuch, Gengrong Lin, Aya Kubo, et al.
The Journal of Antimicrobial Chemotherapy|September 21, 2010
Rapid detection of vancomycin-non-susceptible Staphylococcus aureus using the spiral gradient endpoint techniqueVijaya C Doddangoudar, Margaret M O'Donoghue, Maureen V Boost, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzaeKlaudia Kosowska-Shick, Catherine Clark, Kim Credito, et al.
Antonie Van Leeuwenhoek|August 7, 2008
Molecular characterization of methicillin-resistant Staphylococcus aureus nasal isolates from TurkeyAbdullah Kilic, Gurkan Mert, Zeynep Senses, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agentsKlaudia Kosowska-Shick, Kim L Credito, Glenn A Pankuch, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studiesKlaudia Kosowska-Shick, Catherine Clark, Glenn A Pankuch, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologiesGlenn A Pankuch, Gengrong Lin, Dianne B Hoellman, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2011
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepaciaPamela McGhee, Catherine Clark, Kim Credito, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanismsPamela McGhee, Catherine Clark, Klaudia M Kosowska-Shick, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical CenterKlaudia Kosowska-Shick, Lois M Ednie, Pamela McGhee, et al.
Pageof 15